Total Payments
$1,898
2024 Payments
$67.64
Companies
13
Transactions
26
Medicare Patients
7,228
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$1,445 (76.1%)
Gifts$393.65 (20.7%)
Education$40.56 (2.1%)
Other$19.44 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,445 | 22 | 76.1% |
| Gift | $393.65 | 1 | 20.7% |
| Education | $40.56 | 2 | 2.1% |
| Entertainment | $19.44 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $393.65 | 1 | $0 (2019) |
| Alimera Sciences, Inc. | $268.55 | 2 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $231.83 | 2 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $199.75 | 5 | $0 (2024) |
| Allergan, Inc. | $179.47 | 3 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $153.81 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $151.28 | 2 | $0 (2019) |
| Shire North American Group Inc | $125.00 | 1 | $0 (2017) |
| Genentech, Inc. | $113.21 | 2 | $0 (2022) |
| ABBVIE INC. | $25.98 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.64 | 3 | Regeneron Healthcare Solutions, Inc. ($67.64) |
| 2023 | $99.58 | 4 | Apellis Pharmaceuticals, Inc. ($73.60) |
| 2022 | $315.53 | 4 | Regeneron Healthcare Solutions, Inc. ($119.82) |
| 2021 | $99.66 | 2 | Alimera Sciences, Inc. ($75.76) |
| 2020 | $192.79 | 1 | Alimera Sciences, Inc. ($192.79) |
| 2019 | $657.90 | 5 | Alcon Vision LLC ($393.65) |
| 2018 | $49.05 | 2 | Novartis Pharmaceuticals Corporation ($29.53) |
| 2017 | $416.33 | 5 | Allergan Inc. ($132.92) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $20.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $19.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/31/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $30.82 | General |
| Category: Ophthalmology | ||||||
| 07/10/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: Ophthalmology | ||||||
| 07/06/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: EYE CARE | ||||||
| 03/27/2023 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| 12/07/2022 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $102.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/14/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $80.21 | General |
| 04/20/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $119.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/18/2022 | Genentech, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/11/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: RETINA | ||||||
| 04/16/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $75.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/10/2020 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $192.79 | General |
| Category: Ophthalmology | ||||||
| 10/11/2019 | Novartis Pharmaceuticals Corporation | BUPARLISIB (Drug) | Food and Beverage | In-kind items and services | $121.75 | General |
| 06/27/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: RETINA | ||||||
| 06/12/2019 | Genentech, Inc. | Lucentis (Biological), Non-Covered Product | Food and Beverage | In-kind items and services | $100.41 | General |
| Category: Ophthalmology | ||||||
| 04/04/2019 | OPTOS, INC. | P200DTx (Device), P200T, P200TE | Entertainment | Cash or cash equivalent | $19.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/07/2019 | Alcon Vision LLC | Constellation (Device) | Gift | In-kind items and services | $393.65 | General |
| Category: Ophthalmology | ||||||
| 12/17/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Ophthalmology | ||||||
| 10/28/2018 | Novartis Pharmaceuticals Corporation | BROLUCIZUMAB (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| 12/06/2017 | Regeneron Pharmaceuticals, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $129.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/02/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPTHALMICS | ||||||
| 07/06/2017 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/20/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,579 | 10,749 | $2.6M | $653,262 |
| 2022 | 12 | 1,862 | 3,731 | $2.2M | $528,242 |
| 2021 | 15 | 2,073 | 4,236 | $2.4M | $586,139 |
| 2020 | 15 | 1,714 | 3,345 | $1.8M | $407,760 |
Total Patients
7,228
Total Services
22,061
Medicare Billing
$2.2M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 52 | 376 | $1.0M | $258,736 | 25.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 37 | 7,320 | $780,300 | $212,216 | 27.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 162 | 542 | $212,975 | $49,578 | 23.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 323 | 468 | $174,976 | $39,309 | 22.5% |
| 92134 | Imaging of retina | Office | 2023 | 457 | 1,118 | $133,756 | $32,979 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 390 | $104,468 | $25,797 | 24.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 100 | 270 | $57,680 | $14,721 | 25.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 75 | 75 | $33,255 | $7,105 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $22,329 | $5,611 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 62 | $23,572 | $5,343 | 22.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 22 | 24 | $3,418 | $910.15 | 26.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 46 | 47 | $3,446 | $835.92 | 24.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 12 | 12 | $560.00 | $122.50 | 21.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 67 | 478 | $1.4M | $338,571 | 24.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 170 | 510 | $200,579 | $44,850 | 22.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 323 | 398 | $154,424 | $35,127 | 22.7% |
| 92134 | Imaging of retina | Office | 2022 | 579 | 1,184 | $148,229 | $33,519 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 452 | $126,790 | $29,208 | 23.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 105 | 286 | $63,778 | $15,177 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $53,479 | $11,930 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 115 | $45,505 | $10,312 | 22.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 72 | 72 | $33,058 | $7,166 | 21.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 66 | 66 | $5,016 | $1,138 | 22.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 17 | 18 | $2,654 | $697.15 | 26.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 49 | 49 | $2,361 | $547.04 | 23.2% |
About Dr. Judy Liu, MD
Dr. Judy Liu, MD is a Ophthalmology healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689675720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judy Liu, MD has received a total of $1,898 in payments from pharmaceutical and medical device companies, with $67.64 received in 2024. These payments were reported across 26 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,445).
As a Medicare-enrolled provider, Liu has provided services to 7,228 Medicare beneficiaries, totaling 22,061 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Henderson, NV
- Active Since 08/10/2005
- Last Updated 01/03/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1689675720
Products in Payments
- Constellation (Device) $393.65
- EYLEA (Biological) $222.52
- OZURDEX (Drug) $205.45
- Iluvien (Drug) $192.79
- EYLEA AFLIBERCEPT INJECTION (Biological) $141.42
- XIIDRA (Drug) $125.00
- BUPARLISIB (Drug) $121.75
- Lucentis (Biological) $119.93
- ILUVIEN (Drug) $75.76
- EYLEA HD (Biological) $67.64
- Syfovre (Drug) $54.60
- BROLUCIZUMAB (Drug) $29.53
- P200DTx (Device) $19.44
- ACTHAR (Biological) $16.99
- VABYSMO (Drug) $12.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Henderson
Dr. Rene Zamora, Md, MD
Ophthalmology — Payments: $278,863
Ophthalmology $278,863
Dr. Darrick Neibaur, D.o, D.O
Ophthalmology — Payments: $33,505
Ophthalmology $33,505
Peter Debry, M.d, M.D
Ophthalmology — Payments: $11,578
Ophthalmology $11,578
Dr. Dan Eisenberg, M.d, M.D
Ophthalmology — Payments: $4,569
Ophthalmology $4,569
Dr. Rajy Rouweyha, M.d, M.D
Ophthalmology — Payments: $2,961
Ophthalmology $2,961
Dr. Douglas Lorenz, D.o, D.O
Ophthalmology — Payments: $2,480
Ophthalmology $2,480